Arch Biopartners Inc. (TSXV:ARCH)
Canada
· Delayed Price · Currency is CAD 1.320
+0.020 (1.54%)
Dec 5, 2025, 3:59 PM EST
Arch Biopartners Balance Sheet
Financials in millions CAD. Fiscal year is October - September.
Millions CAD. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | 2019 - 2015 |
| Cash & Equivalents | 0.17 | 0 | 0.83 | 0.51 | 0.45 | 0.65 | Upgrade
|
| Cash & Short-Term Investments | 0.17 | 0 | 0.83 | 0.51 | 0.45 | 0.65 | Upgrade
|
| Cash Growth | 281.05% | -99.64% | 64.17% | 12.96% | -31.43% | 63.27% | Upgrade
|
| Accounts Receivable | - | 0.72 | - | - | 1.85 | - | Upgrade
|
| Other Receivables | 0.06 | 0.17 | 0.3 | 0.09 | 0.35 | 0.06 | Upgrade
|
| Receivables | 0.06 | 0.9 | 0.3 | 0.09 | 2.2 | 0.06 | Upgrade
|
| Prepaid Expenses | 0.04 | 0.03 | 0.04 | 0.03 | 0.02 | 0.03 | Upgrade
|
| Total Current Assets | 0.27 | 0.94 | 1.17 | 0.62 | 2.67 | 0.74 | Upgrade
|
| Total Assets | 0.27 | 0.94 | 1.17 | 0.62 | 2.67 | 0.74 | Upgrade
|
| Accounts Payable | 1.25 | 2.35 | 0.39 | 0.49 | 0.96 | 0.95 | Upgrade
|
| Accrued Expenses | - | 0.04 | 0.17 | 0.19 | 0.42 | 0.27 | Upgrade
|
| Short-Term Debt | 2.67 | 2.27 | 1.71 | - | 1.8 | - | Upgrade
|
| Current Portion of Long-Term Debt | - | 0.5 | 2.6 | 2.1 | - | - | Upgrade
|
| Current Unearned Revenue | - | 0.12 | 1.1 | - | - | - | Upgrade
|
| Total Current Liabilities | 3.92 | 5.28 | 5.98 | 2.78 | 3.19 | 1.22 | Upgrade
|
| Long-Term Debt | - | - | 0.7 | 2.31 | 3.36 | 3.39 | Upgrade
|
| Total Liabilities | 3.92 | 5.28 | 6.68 | 5.09 | 6.55 | 4.61 | Upgrade
|
| Common Stock | 19.22 | 17.42 | 15.88 | 15.55 | 14.76 | 13.71 | Upgrade
|
| Additional Paid-In Capital | 7.68 | 7.51 | 6.66 | 4.7 | 4.68 | 4.57 | Upgrade
|
| Retained Earnings | -33.25 | -31.97 | -28.05 | -24.72 | -23.32 | -22.15 | Upgrade
|
| Comprehensive Income & Other | 2.69 | 2.69 | - | - | - | - | Upgrade
|
| Shareholders' Equity | -3.66 | -4.35 | -5.51 | -4.47 | -3.88 | -3.87 | Upgrade
|
| Total Liabilities & Equity | 0.27 | 0.94 | 1.17 | 0.62 | 2.67 | 0.74 | Upgrade
|
| Total Debt | 2.67 | 2.77 | 5.02 | 4.41 | 5.16 | 3.39 | Upgrade
|
| Net Cash (Debt) | -2.5 | -2.77 | -4.18 | -3.91 | -4.72 | -2.74 | Upgrade
|
| Net Cash Per Share | -0.04 | -0.04 | -0.07 | -0.06 | -0.08 | -0.05 | Upgrade
|
| Filing Date Shares Outstanding | 66.11 | 64.94 | 62.76 | 62.4 | 61.36 | 61.36 | Upgrade
|
| Total Common Shares Outstanding | 66.11 | 64.65 | 62.6 | 62.33 | 61.96 | 60.78 | Upgrade
|
| Working Capital | -3.66 | -4.35 | -4.81 | -2.16 | -0.52 | -0.48 | Upgrade
|
| Book Value Per Share | -0.06 | -0.07 | -0.09 | -0.07 | -0.06 | -0.06 | Upgrade
|
| Tangible Book Value | -3.66 | -4.35 | -5.51 | -4.47 | -3.88 | -3.87 | Upgrade
|
| Tangible Book Value Per Share | -0.06 | -0.07 | -0.09 | -0.07 | -0.06 | -0.06 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.